EZH2 and breast carcinoma: Consistent with our results, HOTAIR is over-expressed in early and metastatic breast cancer cells [21], serves as a prognostic factor for glioma patient [13] and promotes glioblastoma cell cycle progression in an EZH2 dependent manner [14].